People: Biogen Idec Inc (BIIB.O)

BIIB.O on Nasdaq

389.16USD
30 Jan 2015
Change (% chg)

$35.91 (+10.17%)
Prev Close
$353.25
Open
$372.75
Day's High
$397.00
Day's Low
$372.75
Volume
4,029,832
Avg. Vol
1,799,605
52-wk High
$397.00
52-wk Low
$272.02

Search Stocks

Denner, Alexander 

Brief Biography

Dr. Alexander J. Denner, Ph.D. is Independent Director of Biogen Idec Inc., since June 2009. Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP, a registered investment advisor formed in 2012. Sarissa Capital focuses on improving the strategies of companies to better provide shareholder value. From 2006 to 2011, Dr. Denner served as a Senior Managing Director at Icahn Capital, an entity through which Carl C. Icahn conducts his investment activities. Prior to that, he served as a portfolio manager at Viking Global Investors, a private investment fund, and Morgan Stanley Investment Management, a global asset management firm. Dr. Denner is also a director of VIVUS Inc. and Ariad Pharmaceuticals, Inc., both biopharmaceutical companies. During the past five years, Dr. Denner has also served as a director of the following healthcare companies: Amylin Pharmaceuticals, Inc., Mast Therapeutics, Inc. (formerly Adventrx Pharmaceuticals, Inc.), Enzon Pharmaceuticals, Inc. and ImClone Systems Incorporated, where he also served as Chairman of the Executive Committee.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stelios Papadopoulos

--

George Scangos

15,015,100

Paul Clancy

4,486,260

Kenneth Di Pietro

3,254,520

Susan Alexander

2,162,200

John Cox

3,671,600
As Of 30 Dec 2013
Search Stocks